Scientists from Far Eastern Federal University have developed a new synthetic derivative of fascaplysin—a biologically active substance with antitumoral properties obtained from sea sponges. Biological tests have shown that the compound is two to three times more active than fascaplysin. The results of the study were published in the well-known scientific journal Tetrahedron Letters.